In Vitro Fertilization Market (2026 - 2033)

In Vitro Fertilization Market Summary

The global in vitro fertilization market was valued at USD 28.5 billion in 2025 and is projected to grow from USD 30.1 billion in 2026 to USD 43.7 billion in 2033, at a CAGR of 5.5% from 2026 to 2033. Europe dominated the market, accounting for the largest revenue share of 37.0% in 2025. Rising reproductive tourism and increasing cases of male & female infertility are key factors driving the market growth.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

Key Market Trends & Insights

• By instrument: The culture media segment held the largest market share of approximately 41.0% in 2025.
• By procedure type: The frozen non-donor segment held the largest market share in 2025.
• By providers: The fertility clinics segment held the largest market share in 2025.

Regional Highlights

• Largest regional market: Europe (37.0% revenue share, 2025)
• Fastest-growing regional market: Asia Pacific (highest CAGR, 2026-2033)

Market Size & Forecast

• Market size in 2025: USD 28.5 Billion
• Estimated market size in 2026: USD 30.1 Billion
• Projected market size by 2033: USD 43.7 Billion
• CAGR (2026-2033): 5.5%

Infertility is one of the major health concerns faced by individuals globally. According to the WHO, around 17.5% of the adult population worldwide experiences infertility. This highlights the necessity of enhancing access to affordable, high-quality fertility care globally. The American Pregnancy Association states that male infertility constitutes 30% of overall infertility cases and contributes to approximately one-fifth of all infertility instances in the U.S. The average age at which individuals marry and have their first child is increasing. This trend has increased the number of women seeking IVF treatment. Moreover, to focus on their career, many women freeze their eggs to have a child at a later stage. Rising dependence on fertility treatments is expected to aid market growth. The availability of funds is leading to a rise in the adoption of in-vitro fertilization (IVF) procedures.

To increase the success rate of IVF, techniques such as egg/sperm freezing, vitrification, assisted hatching, Percutaneous Epididymal Sperm Aspiration & Testicular Sperm Extraction (PESA and TESE), are being introduced along with the development of new products. In June 2025, Cercle entered a global distribution partnership with MedITEX, extending access to its AI platform across fertility and genetics clinics throughout Europe. Such developments are expected to boost the efficacy of in-vitro procedures and, hence, encourage the market growth even further.

To compete in a modern business environment, all organizations (manufacturers, clinics, and hospitals) must develop their virtual presence to increase awareness about infertility treatment and their services. As infertility is a sensitive issue, people are reluctant to discuss it openly, particularly in developing countries. Hence, developing authenticity and trust through digital platforms is a key challenge for service providers. The providers can take an initial step to gain a center’s or manufacturer’s trust by displaying a hospital’s or approval committee’s certificates, introducing doctors or scientists, and sharing their coordinates to establish & authenticate their identity.

Analyst Perspective

The global in vitro fertilization market is driven by higher incidence of infertility worldwide, growing parental age, and increasing awareness about assisted reproductive technology (ART) solutions. However, extending fertility solutions to emerging countries, leveraging digital tools for enhanced patient interaction, expanding investment in reproductive health care solutions, and continued innovation in AI-driven diagnostics and treatment strategies in the fertility sector are some key opportunities that help to grow in the market. Although high cost, limited insurance coverage, and social stigma associated with the process might hinder the growth of the market.

Instrument Insights

The culture media segment dominated the market with the largest revenue share of approximately 41.0% in 2025. This can be attributed to factors such as the availability of funding and an increase in research activities to improve culture media. Culture media play a vital role in the success of in vitro fertilization by creating a controlled environment. It mimics physiological conditions, enabling proper fertilization and embryo development. Continuous advancements in media formulations are enhancing embryo quality, improving implantation outcomes, and supporting the growing adoption of IVF procedures worldwide.

The disposable devices segment is expected to grow at the fastest CAGR during the forecast years. The growth of this segment is owing to industry players introducing disposable devices, such as slides, needles, and chambers, to meet sterility and regulatory requirements. Such developments are expected to increase the adoption of disposable IVF devices. Disposable slides for sperm counting, an imaging-based tracking system to isolate the best motile sperm, and the use of disposable microchips are some of the innovations witnessed by the market in recent years.

Procedure Type Insights

The frozen non-donor segment dominated the market with the largest revenue share in 2025 and is expected to witness the fastest growth over the forecast period. Certain factors contributing to high share are cost-effectiveness as compared to fresh non-donor and the less invasive nature of the procedure. The fresh donor segment is expected to grow significantly over the forecast period.

Although some centers offer risk-sharing plans and refunds for only three cycles, Advanced Fertility Center of Chicago has designed an IVF reimbursement plan that provides a 100% refund for up to four cycles with fresh embryos. The Human Fertilization and Embryology Act 1990 does not cover fresh sperm donation, and hence, there is rising concern about sperm donors not being screened before donation. HEFA does not guarantee sperm donation services, which are unlicensed. Hence, HEFA has revised its guidelines, wherein fresh sperm must be quarantined for 180 days for HIV screening. NHS funds a smaller proportion of fertility treatment using donated gametes for homosexuals and single parents.

Providers Insights

The fertility clinics segment dominated the market with the largest revenue share in 2025 and is expected to witness the fastest growth over the forecast period. This can be attributed to a rise in demand for ART treatments; the number of fertility clinics and ART centers is increasing considerably. Factors, such as cost-effectiveness, availability of specialists, and minimal or no chances of Hospital-Acquired Infections (HAIs), are anticipated to drive the growth of the fertility clinics segment. IVF treatments are also performed in hospitals.

The hospitals and other settings segments is expected to grow at a significant CAGR over the forecast period. Numerous multi-specialty hospitals provide infertility treatments, including in vitro fertilization (IVF). Growing accessibility and availability of these treatments have contributed to a greater inclination toward hospitals for infertility care. However, hospital IVF treatments cost more than fertility clinics. This is partly due to the need for highly skilled physicians and staff to perform these intricate procedures. Consequently, having dedicated IVF staff in hospitals is considered less favored due to the costs of their employment, remuneration, and training. These costs can be particularly high in developed countries such as the U.S. and the UK.

Regional Insights

Europe dominated the market with the largest revenue share of approximately 37.0% in 2025. This can be attributed to factors, such as a noticeable surge in medical tourism, with an increasing number of Americans choosing to travel to the Czech Republic for more cost-effective IVF treatments. Moreover, individuals who cannot afford to travel abroad are now seeking IVF treatments within the United States at around one-third of the cost charged by clinics in the country.

To learn more about this report, Download Free Sample Report

North America In Vitro Fertilization Market Trends

North America is also expected to witness increasing demand for fertility treatment in the coming years. Lifestyle changes, including insufficient nutrition, stress, increased obesity, improper eating habits, rise in pollution, lack of exercise, and prevalence of medical conditions like diabetes, have led to a higher incidence of infertility in the region. The growth can be attributed to several factors such as standardization of procedures through regulatory reforms, automation, government funding for egg/sperm storage, and introduction of more IVF treatments by industry players. Continuous development in the IVF technology and integration of AI in the process is further increasing the success rate of the procedure. In June 2026, FDA approves use of AI in IVF embryo assessment and selection tool. The solution is provided by ALIFE Health and conducted trails on 440 patients across its 7 clinics.

Growth of the U.S. in vitro fertilization market is driven by various factors, with one significant factor being the notable increase in infertility rates. Infertility affects a considerable number of couples in the U.S., with approximately one in eight couples experiencing difficulties in conceiving.

Asia Pacific In Vitro Fertilization Market Trends

The demand for IVF treatments is expected to increase in the Asia Pacific region owing to the growth in fertility tourism, the increase in the number of international companies trying to penetrate economically developing countries, and the change in the regulatory landscape in APAC. The Asia Pacific Initiative on Reproduction (ASPIRE) is a task force of clinicians & scientists engaged in the management of fertility & ART. This promotes awareness regarding infertility & ART and enhances infertility-related services in the region. According to OECD, in 2024, the birth rate in the Asia Pacific had fallen to a population replacement rate of 1.40 children born per woman. A decrease in the birth rate and an increase in the geriatric population are among the key factors expected to propel market growth.

The India in vitro fertilization market experienced a remarkable increase in demand for IVF services. This surge can be attributed to several factors, including delayed marriages, a rise in the average age of pregnancy, an increase in infertility rates, higher disposable income levels, and awareness about the availability of infertility treatments. The average cost of IVF services in India ranges from USD 1,000 to USD 3,000.

Key In Vitro Fertilization Company Insights

The market is moving towards the maturation phase with strong growth momentum with the increasing demand and supply chain capabilities in developing countries. Geographical expansions, mergers, and product innovations & commercialization are key strategies adopted by the market players.

Key In Vitro Fertilization Companies

The following key companies have been profiled for this study on the in vitro fertilization market:

• Cook Medical LLC

• EMD Serono, Inc.

• Ferring B.V.

• FUJIFILM Irvine Scientific (FUJIFILM Holdings Corporation)

• Genea Biomedx

• EMD Serono, Inc. (Merck KGaA)

• The Cooper Companies, Inc.

• Thermo Fisher Scientific, Inc.

• Vitrolife

Recent Developments

• In April 2026, Gaudium IVF, an innovation leader in India’s fertility healthcare sector, has introduced India’s first artificial intelligence (AI)-led infertility treatment. The treatment includes SiD (Sperm Identification Device) and ERICA (Embryo Ranking Intelligent Classification Assistant).

• In August 2025, Nova IVF Fertility has integrated Artificial Intelligence (AI) in IVF labs. This integration is to enhance precision and transparency in embryo selection.

Global In Vitro Fertilization Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the global in vitro fertilization market report based on instrument, procedure type, providers, and region:

• Instrument Outlook (Revenue, USD Billion, 2021 - 2033)

  • Disposable Devices

  • Culture Media

    • Cryopreservation Media

    • Embryo Culture Media

    • Ovum Processing Media

    • Sperm Processing Media

  • Equipment

    • Sperm Analyzer Systems

    • Imaging Systems

    • Ovum Aspiration Pumps

    • Micromanipulator Systems

    • Incubators

    • Gas Analyzers

    • Laser Systems

    • Cryosystems

    • Sperm Separation Devices

    • IVF Cabinets

    • Anti-vibration Tables

    • Witness Systems

    • Other

• Procedure Type Outlook (Revenue, USD Billion, 2021 - 2033)

  • Fresh Donor

  • Frozen Donor

  • Fresh Non-donor

  • Frozen Non-donor

• Providers Outlook (Revenue, USD Billion, 2021 - 2033)

  • Fertility Clinics

  • Hospitals & Others Setting

• Regional Outlook (Revenue, USD Billion, 2021 - 2033)

  • North America

    • U.S.

    • Canada

  • Europe

    • France

    • Germany

    • Italy

    • Spain

    • UK

    • Belgium

    • Netherlands

    • Switzerland

    • Norway

    • Denmark

    • Sweden

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • Middle East and Africa

    • South Africa

    • Saudi Arabia

    • UAE